Adagio Medical Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Adagio Medical Holdings, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Dec 2021
Revenue & Gross Profit
Revenue0.270.300.190.27
Cost of Revenue1.941.310.881.16
Gross Profit-1.67-1.01-0.69-0.89
Operating Expenses
Research & Development4.6315.4017.8615.36
Selling, General & Administrative6.9811.545.374.40
Operating Expenses60.8126.9423.2319.76
Operating Income-62.48-27.94-23.91-20.65
Other Income/Expense
Interest Income0.420.000.040.00
Interest Expense-1.101.660.140.00
Other Income/Expense8.72-8.550.34-0.04
Income
Income Before Tax-53.76-38.15-23.67-19.94
Income Tax Expense0.000.000.000.00
Net Income-53.76-38.15-23.67-19.94
Net Income - Continuous Operations-53.76-38.15-23.67-19.94
Net Income - Discontinued Operations0.000.000.000.00
EBITDA-62.48-35.96-23.04-20.31
EBIT-34.96-36.49-23.54-20.65
Depreciation & Amortization-7.610.530.500.34
Earnings Per Share
Basic EPS-4.00-3.00-2.00-27.00
Diluted EPS-4.00-3.00-2.00-27.00
Basic Shares Outstanding15.2013.3913.390.73
Diluted Shares Outstanding15.2013.3913.390.73